| Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease BG Trist, DJ Hare, KL Double Aging cell 18 (6), e13031, 2019 | 610 | 2019 |
| Brain iron pathways and their relevance to Parkinson's disease D Berg, M Gerlach, MBH Youdim, KL Double, L Zecca, P Riederer, ... Journal of neurochemistry 79 (2), 225-236, 2001 | 507 | 2001 |
| Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease H Fedorow, F Tribl, G Halliday, M Gerlach, P Riederer, KL Double Progress in neurobiology 75 (2), 109-124, 2005 | 466 | 2005 |
| Language-associated cortical regions are proportionally larger in the female brain J Harasty, KL Double, GM Halliday, JJ Kril, DA McRitchie Archives of neurology 54 (2), 171-176, 1997 | 386 | 1997 |
| The relevance of iron in the pathogenesis of Parkinson's disease ME Götz, KAY Double, M Gerlach, MBH Youdim, P RIEDERERE Annals of the New York Academy of Sciences 1012 (1), 193-208, 2004 | 374 | 2004 |
| Regional specificity of brain atrophy in Huntington's disease GM Halliday, DA McRitchie, V Macdonald, KL Double, RJ Trent, ... Experimental neurology 154 (2), 663-672, 1998 | 346 | 1998 |
| Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease H Hall, S Reyes, N Landeck, C Bye, G Leanza, K Double, L Thompson, ... Brain 137 (9), 2493-2508, 2014 | 322 | 2014 |
| Iron and dopamine: a toxic couple DJ Hare, KL Double Brain 139 (4), 1026-1035, 2016 | 284 | 2016 |
| Topography of brain atrophy during normal aging and Alzheimer's disease KL Double, GM Halliday, JJ Krill, JA Harasty, K Cullen, WS Brooks, ... Neurobiology of aging 17 (4), 513-521, 1996 | 271 | 1996 |
| α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease GM Halliday, A Ophof, M Broe, PH Jensen, E Kettle, H Fedorow, ... Brain 128 (11), 2654-2664, 2005 | 247 | 2005 |
| Copper pathology in vulnerable brain regions in Parkinson's disease KM Davies, S Bohic, A Carmona, R Ortega, V Cottam, DJ Hare, ... Neurobiology of aging 35 (4), 858-866, 2014 | 241 | 2014 |
| Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum M Gerlach, K Double, T Arzberger, F Leblhuber, T Tatschner, P Riederer Journal of neural transmission 110, 1119-1127, 2003 | 236 | 2003 |
| Iron-binding characteristics of neuromelanin of the human substantia nigra KL Double, M Gerlach, V Schünemann, AX Trautwein, L Zecca, ... Biochemical pharmacology 66 (3), 489-494, 2003 | 233 | 2003 |
| In vitro studies of ferritin iron release and neurotoxicity KL Double, M Maywald, M Schmittel, P Riederer, M Gerlach Journal of neurochemistry 70 (6), 2492-2499, 1998 | 217 | 1998 |
| The comparative biology of neuromelanin and lipofuscin in the human brain KL Double, VN Dedov, H Fedorow, E Kettle, GM Halliday, B Garner, ... Cellular and Molecular Life Sciences 65, 1669-1682, 2008 | 216 | 2008 |
| Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test KL Double, DB Rowe, M Hayes, DKY Chan, J Blackie, A Corbett, R Joffe, ... Archives of neurology 60 (4), 545-549, 2003 | 212 | 2003 |
| Localization of copper and copper transporters in the human brain KM Davies, DJ Hare, V Cottam, N Chen, L Hilgers, G Halliday, JFB Mercer, ... Metallomics 5 (1), 43-51, 2013 | 158 | 2013 |
| Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? KL Double, S Reyes, EL Werry, GM Halliday Progress in neurobiology 92 (3), 316-329, 2010 | 153 | 2010 |
| Potential sources of increased iron in the substantia nigra of parkinsonian patients M Gerlach, KL Double, MBH Youdim, P Riederer Parkinson’s Disease and Related Disorders, 133-142, 2006 | 151 | 2006 |
| Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins KL Double, L Zecca, P Costi, M Mauer, C Griesinger, S Ito, ... Journal of neurochemistry 75 (6), 2583-2589, 2000 | 149 | 2000 |
